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Abstract
It is now recognised that the breast exhibits a circadian rhythm which reflects its physiology. There
is increasing evidence that rhythms associated with malignant cells proliferation are largely non-
circadian and that a circadian to ultradian shift may be a general correlation to neoplasia.
Cancer development appears to generate its own thermal signatures and the complexity of these
signatures may be a reflection of its degree of development.
The limitations of mammography as a screening modality especially in young women with dense
breasts necessitated the development of novel and more effective screening strategies with a high
sensitivity and specificity. Dynamic thermal analysis of the breast is a safe, non invasive approach
that seems to be sensitive for the early detection of breast cancer.
This article focuses on dynamic thermal analysis as an evolving method in breast cancer detection
in pre-menopausal women with dense breast tissue. Prospective multi-centre trials are required to
validate this promising modality in screening.
The issue of false positives require further investigation using molecular genetic markers of
malignancy and novel techniques such as mammary ductoscopy.
Introduction
Breast cancer is one of the most common cancers, it is esti-
mated that one in eight women in the USA will develop
breast cancer during their lifetime [1-4]. Furthermore, 25–
30% of breast cancers are found in pre-menopausal
women [1]. Currently mammography is the best available
approach for the early detection of breast cancer in the
general population with a sensitivity of 75–90% [2].
However, the positive predictive value is only 25% [3,4].
In addition to mammography, non invasive new modali-
ties have been developed to allow the early detection of
breast cancer in all age groups and more importantly in
young women with dense breast tissue and women who
have high risk of developing breast cancer such as, women
with strong family history and carriers of BRCA1 and/or
BRCA2 genes.
Currently, magnetic resonance imaging (MRI) is being
studied for the early detection of breast cancer. Its
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sensitivity in high risk women has been found to be much
higher than mammography but with a lower specificity
[5,6]. Kriege et al observed a higher sensitivity for MRI in
detection of breast cancer in women with a genetic predis-
position or at high risk compared to (71% vs. 41 %) but
with lower specificity (90% vs. 95%) [6].
Electrical impedance scanning (EIS) is another modality
under development for breast cancer detection especially
in young women with dense breasts [7]. The basic science
behind its use is the fact that malignant tumours have
lower electrical impedance than the surrounding normal
tissue. However, separation between malignant and
benign lesions needs further investigations [8].
Furthermore, mammary ductoscopy (MD) and visualiza-
tion of mammary ducts and proteomics of nipple aspirate
fluid (NAF) and serum are promising screening modali-
ties that require further evaluation [9,10].
The limitations of mammography as a screening modality
especially in young women with dense breasts necessi-
tated the development of novel and more effective screen-
ing strategies with a high sensitivity and specificity.
This article focuses on the dynamic thermal analysis as an
evolving non invasive and a safe method in breast cancer
detection in pre-menopausal women with dense breast
tissue and women at high risk due to family history or
genetic predisposition.
Breast and circadian rhythm [1]
It is now recognised that the establishment and growth of
a tumour depend on neovascularization. This successful
recruitment of new blood vessels into a tumour; also
known as angiogenesis is dependent on angiogenic
growth factors produced by the tumour cells [11]. Such
new vessels grow adjacent to the tumour presumably to
increase its nutrient supply [12]. These new vessels lack
smooth muscles rendering them unreceptive to control by
epinephrine [13,14]. The lack of receptivity produce a
more constant blood flow, thus increasing the local
temperature.
Earlier technology for assessing thermal abnormalities in
the breast focussed on the presence of the abnormal tem-
perature as a crucial marker [15-17]. In a study conducted
by Gantherine et al, 21.3% of patients who had abnormal
thermograms but no abnormality on physical examina-
tion and mammography developed breast cancer within
the next 3 years [17]. In another study of women who had
thermal abnormalities on initial examination using infra-
red technology, long term follow up (2–10 years) revealed
that 33% of these women developed breast cancer, a rate
six times higher than that expected in the normal popula-
tion [18]. This relationship between breast skin tempera-
ture and breast cancer was thoroughly examined by Gros
et al [15,16]. They found that the differences between the
characteristics of rhythmic changes in skin temperature of
clinically healthy and cancerous breasts were real and
measurable. Despite these interesting observations ther-
mography as a general screening tool for the detection of
women at risk of breast cancer did not find a wide spread
acceptance due to low sensitivity of the test and the sub-
jective nature of the test interpretations.
The superficial thermal patterns measured on the surface
of the breast seem to be related to tissue metabolism and
vascularization within the underlying tissue. Such thermal
patterns change significantly as a result of normal phe-
nomena including menstrual cycle, pregnancy and more
importantly the pathologic process itself. Additionally,
cancer development represents the summation of a large
number of mutations that occur over years, each with its
own particular histologic phenotype [19-23].
Such changes appear to generate their own thermal signa-
ture and the complexity of these signatures may be a
reflection of their degree of development [24-28].
Temperature in a normal breast increases from the skin
into the deep tissue and heat conductivity in the healthy
breasts is constant in most cases and generally can be char-
acterized in terms of circadian rhythm periodicity [29]. In
contrast, the rhythms associated with malignant cells pro-
liferation are largely non circadian and suggest that a cir-
cadian to ultradian shift may be a general correlation to
neoplasia. Heat production by the tumour under the
influence of angiogenesis should be therefore re-exam-
ined in terms of absence of normal circadian fluctuations.
Due to the increased blood flow and the lack of receptivity
in the newly formed vessels in malignancy, temperature
production exhibits circadian rhythmic variations to a far
lesser degree than is evident in the healthy breasts [13]. It
has been found that independent of a tumour's size, rela-
tively small tumours (>/= 0.5 cm in diameter), poorly vas-
cularized rapidly growing tumors can produce increases in
regional heat. The explanation for this effect is unclear but
it may be due to the chronic inflammatory response
around developing breast tumours. With increasing evi-
dence that inflammation can enhance tumor growth and
is associated with a poor prognosis, this suggestion
implies that thermal analysis may have considerable value
[30].
Furthermore, the unique relationship between the ther-
mal circadian rhythm and mitotic activity could be con-
sidered as a first warning of tumour development, which
can be detected using a safe and non-invasive technology.
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central players in gene regulation throughout the organ-
ism, particularly for cell-cycle regulatory genes and the
genes of apoptosis [31].
Dynamic thermal analysis
Recent technological advances have facilitated the record-
ing of circadian rhythm variations of the breast and ana-
lysing the recorded data using highly complicated
computer statistical software. A miniaturized microproc-
essor has been developed to record and store thermal
information collected from eight separate sites of each
breast. Sensors are placed in anatomically critical posi-
tions elicited by data obtained from tumour registries as
to where cancers are most likely to develop.
In the First Warning System (FWS, Lifeline Biotechnolo-
gies, Florida, USA), thermal data are collected every five
minutes for a period of 48 hours during which time
women are encouraged to maintain their daily activities.
9000 pieces of data are recorded by microprocessors dur-
ing the test period and analysed using specially developed
statistical software. Temperature points from each contral-
ateral sensor are plotted against each other to form a ther-
mal motion picture of a lesion's physiological activity.
Such a technology was first used by Farrar et al who exam-
ined a cohort of 138 women who had been scheduled for
open breast biopsies based on the finding of physical
examination and mammography [14]. A total of 23
women (17%) were found to have breast cancer, of these,
20 (87%) were characterized by the monitor as being high
risk. The other 3 patients (13%) who were missed by the
monitor had ductal carcinoma. Mammography was posi-
tive or suspicious in only 19 patients (83%). Of the 4 can-
cers missed by mammography (3 of them were pre
menopausal), the monitor correctly characterized 3
women as being high risk. Figures 1 and 2 demonstrate
the thermal graphs in two patients with a fibroadenoma
(Fig. 1) and a T1 breast cancer (Fig. 2). A neural net algo-
rithm was subsequently developed and evaluated by the
authors because of its value in analysing the non-linear
data such as these recorded by the breast's monitors.
Using this neural net algorithm reduced the number of
false positives (18% vs. 30%)) and improved sensitivity
(91% vs. 87%).
One of the main challenges to this technology is the false
positive cases; confusion could be created in these women
who are characterized as being positive or high risk by
dynamic thermal analysis in the absence of physical and
mammographical signs. This group of women may or
may not have cancer in its earliest stages. Further retro-
spective analysis of the thermal data using a refined neural
net algorithm may increase the sensitivity and reduce the
number of false positives. Also this group of patients may
well benefit from the new advances in the nipple aspirate
fluid analysis and proteomic profiling technologies.
Research is currently ongoing on this subject and the ini-
tial results are promising [9].
The Future
Dynamic thermal analysis of the breast is a safe, non inva-
sive approach that seems to be sensitive for the early
detection of breast cancer especially in young women
Dynamic thermal analysis in a patient with fibroadenoma Figure 1
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where the conventional mammography is of limited
value. Such a technology could become the initial breast
screening test in pre-menopausal women and those who
are classified as positive can then be selected for anatomi-
cal imaging with mammography, MRI and/or ultrasonog-
raphy. Further refinement of the neural net algorithm is
required in order to shorten the period of data recording
and improve specificity. Prospective multi-centre trials are
then required to validate these promising observations.
The issue of false positives require further investigation
using molecular genetic markers of malignancy and novel
techniques such as mammary ductoscopy [10].
Finally, a better understanding of the circadian rhythm
biology [1,30] and clearer definition of the thermal activ-
ity boundaries for various pathological conditions of the
breast will open the door to a new and more precise
screening method for breast cancer.
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